Allspring Global Investments’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,676
| Closed | -$165K | – | 1947 |
|
|
2024
Q3 | $165K | Sell |
5,676
-421
| -7% | -$12.3K | ﹤0.01% | 1711 |
|
|
2024
Q2 | $142K | Sell |
6,097
-63
| -1% | -$1.46K | ﹤0.01% | 1786 |
|
|
2024
Q1 | $126K | Buy |
6,160
+519
| +9% | +$10.7K | ﹤0.01% | 1799 |
|
|
2023
Q4 | $121K | Buy |
5,641
+475
| +9% | +$10.2K | ﹤0.01% | 1772 |
|
|
2023
Q3 | $107K | Sell |
5,166
-327
| -6% | -$6.75K | ﹤0.01% | 1973 |
|
|
2023
Q2 | $162K | Sell |
5,493
-115
| -2% | -$3.39K | ﹤0.01% | 1877 |
|
|
2023
Q1 | $129K | Buy |
5,608
+2,366
| +73% | +$54.5K | ﹤0.01% | 1946 |
|
|
2022
Q4 | $90.2K | Sell |
3,242
-71
| -2% | -$1.98K | ﹤0.01% | 2107 |
|
|
2022
Q3 | $101K | Buy |
3,313
+1,005
| +44% | +$30.6K | ﹤0.01% | 2079 |
|
|
2022
Q2 | $67K | Sell |
2,308
-37,909
| -94% | -$1.1M | ﹤0.01% | 2169 |
|
|
2022
Q1 | $1.29M | Buy |
40,217
+1,605
| +4% | +$51.6K | ﹤0.01% | 1737 |
|
|
2021
Q4 | $1.72M | Buy |
+38,612
| New | +$1.72M | ﹤0.01% | 1621 |
|